P2-320: Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pre-treated lung cancer patient with a metastatic large cell neuroendocrine tumour

Authors :: Joe Rahamim
Bruce Lyons
Siva Shivasankar
Ioannis Gounaris
Dennis Yiannakis
Sarah Earl
Source :: Journal of Thoracic Oncology. 2:S700
Publication Year :: 2007
Publisher :: Elsevier BV, 2007.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Temozolomide
business.industry
Large cell
medicine.disease
Neuroendocrine tumour
Internal medicine
medicine
Lung cancer
Cisplatin/Docetaxel
business
medicine.drug

Full Text Access

Tools